Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 35 citing articles:

Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases
Keith D. Lindor, Christopher L. Bowlus, James L. Boyer, et al.
Hepatology (2018) Vol. 69, Iss. 1, pp. 394-419
Open Access | Times Cited: 676
APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis
Hong You, Xiong Ma, Cumali Efe, et al.
Hepatology International (2022) Vol. 16, Iss. 1, pp. 1-23
Open Access | Times Cited: 82
Extrahepatic Autoimmune Conditions Associated with Primary Biliary Cirrhosis
Annarosa Floreani, I. Franceschet, Nora Cazzagon, et al.
Clinical Reviews in Allergy & Immunology (2014) Vol. 48, Iss. 2-3, pp. 192-197
Closed Access | Times Cited: 182
A pilot study of umbilical cord‐derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis
Lifeng Wang, Jin Li, Honghong Liu, et al.
Journal of Gastroenterology and Hepatology (2013) Vol. 28, Iss. S1, pp. 85-92
Closed Access | Times Cited: 175
CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis
Lifeng Wang, Ying Sun, Zheng Zhang, et al.
Hepatology (2014) Vol. 61, Iss. 2, pp. 627-638
Open Access | Times Cited: 102
Primary Biliary Cholangitis: Its Pathological Characteristics and Immunopathological Mechanisms
Koichi Tsuneyama, Hayato Baba, Yuki Morimoto, et al.
The Journal of Medical Investigation (2017) Vol. 64, Iss. 1.2, pp. 7-13
Open Access | Times Cited: 80
Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis
Tom H. Karlsen, Mette Vesterhus, Kirsten Muri Boberg
Alimentary Pharmacology & Therapeutics (2013) Vol. 39, Iss. 3, pp. 282-301
Open Access | Times Cited: 79
Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis
Jun Zhang, Weici Zhang, Patrick S.C. Leung, et al.
Hepatology (2014) Vol. 60, Iss. 5, pp. 1708-1716
Open Access | Times Cited: 73
Role of autoantibodies in the clinical management of primary biliary cholangitis
Eirini I. Rigopoulou, Dimitrios P. Bogdanos
World Journal of Gastroenterology (2023) Vol. 29, Iss. 12, pp. 1795-1810
Open Access | Times Cited: 16
Shotgun proteomics: Identification of unique protein profiles of apoptotic bodies from biliary epithelial cells
Ana Lleó, Weici Zhang, W. Hayes McDonald, et al.
Hepatology (2014) Vol. 60, Iss. 4, pp. 1314-1323
Open Access | Times Cited: 66
Primary biliary cholangitis: molecular pathogenesis perspectives and therapeutic potential of natural products
Yanling Zhao, Shizhang Wei, Lisheng Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3+ regulatory T cells
Hajime Tanaka, W. Zhang, G-X Yang, et al.
Clinical & Experimental Immunology (2014) Vol. 178, Iss. 2, pp. 253-261
Open Access | Times Cited: 47
E. coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinants
Yao Yang, Jinjung Choi, Ying Chen, et al.
Hepatology (2021) Vol. 75, Iss. 2, pp. 266-279
Closed Access | Times Cited: 31
Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021)
Hong You, Weijia Duan, Shuxiang Li, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 11
Emperipolesis mediated by CD8 + T cells correlates with biliary epithelia cell injury in primary biliary cholangitis
Suxian Zhao, Wen‐cong Li, Na Fu, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 24, Iss. 2, pp. 1268-1275
Open Access | Times Cited: 27
The Role of Inflammation in Cholestatic Liver Injury
Jie Chen, Shujun Zhang
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 4527-4540
Open Access | Times Cited: 7
Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis
Takashi Himoto, Mikio Nishioka
Autoimmunity Highlights (2013) Vol. 4, Iss. 2, pp. 39-53
Open Access | Times Cited: 26
Unmet needs in the treatment of autoimmunity: From aspirin to stem cells
Christopher Chang
Autoimmunity Reviews (2014) Vol. 13, Iss. 4-5, pp. 331-346
Closed Access | Times Cited: 24
Antimitochondrial Antibody–Negative Primary Biliary Cholangitis
David M. Chascsa, Keith D. Lindor
Clinics in Liver Disease (2018) Vol. 22, Iss. 3, pp. 589-601
Closed Access | Times Cited: 18
Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments
Palak Trivedi, Sue Cullen
Hepatology International (2012) Vol. 7, Iss. 1, pp. 28-47
Closed Access | Times Cited: 16
Role of autoimmunity in primary biliary cirrhosis
Tian‐Yan Shi
World Journal of Gastroenterology (2012) Vol. 18, Iss. 48, pp. 7141-7141
Open Access | Times Cited: 15
Primary Biliary Cholangitis
Muhammad Salman Faisal, Humberto C. González, Stuart C. Gordon
Clinics in Liver Disease (2023) Vol. 28, Iss. 1, pp. 63-77
Closed Access | Times Cited: 4
B cell depletion in treating primary biliary cirrhosis: Pros and cons
Yufeng Yin
World Journal of Gastroenterology (2012) Vol. 18, Iss. 30, pp. 3938-3938
Open Access | Times Cited: 12
Autoantibodies in Primary Biliary Cholangitis
Kristel Leung, Gideon M. Hirschfield
Clinics in Liver Disease (2022) Vol. 26, Iss. 4, pp. 613-627
Closed Access | Times Cited: 7
Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice
Yuki Moritoki, Koichi Tsuneyama, Yuka Nakamura, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top